Skip to main navigation Skip to search Skip to main content

HIV-2 Encephalitis: Case Report and Literature Review

  • BR Wood
  • , JP Klein
  • , JL Lyons
  • , DA Milner
  • , RE Phillips
  • , M (Martin) Schutten
  • , RD Folkerth
  • , P Ciarlini
  • , TJ Henrich
  • , JA Johnson

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)

Abstract

We report the case of a 59-year-old man who moved from Cape Verde to Massachusetts at the age of 29. He had multiple sexual contacts with female partners in Cape Verde and with West African women in Massachusetts, as well as multiple past indeterminate HIV-1 antibody tests. He presented to our facility with 2-3 months of inappropriate behaviors, memory impairment, weight loss, and night sweats, at which time he was found to have an abnormal enhancing lesion of the corpus collosum on brain magnetic resonance imaging (MRI). Laboratory testing revealed a CD4 count of 63 cells/mm(3), positive HIV-2 Western blot, serum HIV-2 RNA polymerase chain reaction (PCR) of 1160 copies per milliliter and cerebrospinal fluid (CSF) HIV-2 RNA PCR of 2730 copies per milliliter. Brain biopsy demonstrated syncytial giant cells centered around small blood vessels and accompanied by microglia, which correlated with prior pathologic descriptions of HIV-2 encephalitis and with well-described findings of HIV-1 encephalitis. Based on genotype resistance assay results, treatment guidelines, and prior studies validating success with lopinavir-ritonavir, he was treated with tenofovir-emtricitabine and lopinavir-ritonavir, which has led to virologic suppression along with steady neurologic and radiologic improvement, although he continues to have deficits.
Original languageUndefined/Unknown
Pages (from-to)383-387
Number of pages5
JournalAIDS Patient Care and STDs
Volume26
Issue number7
DOIs
Publication statusPublished - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research programs

  • EMC MM-04-27-01

Cite this